J Martin Carroll Esperion Therapeutics, Inc. (ESPR) insider trading activity
J Martin Carroll is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 97,650 shares of ESPR, which is worth approximately $112,297. The most recent transaction as insider was on May 29, 2025, when has been sold 33,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
97.7K
51.04%
3M change
51.04%
12M change
Total Value Held
$112,297
J MARTIN CARROLL Transaction History
Also insider at
JMC
J Martin Carroll
Director
Somerset, NJ